These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2169060)

  • 21. Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms.
    Boyle JJ; Weissberg PL; Bennett MR
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1553-8. PubMed ID: 12869351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphotoxin and LIGHT signaling pathways and target genes.
    Schneider K; Potter KG; Ware CF
    Immunol Rev; 2004 Dec; 202():49-66. PubMed ID: 15546385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ligands and receptors of the lymphotoxin system.
    Ware CF; VanArsdale TL; Crowe PD; Browning JL
    Curr Top Microbiol Immunol; 1995; 198():175-218. PubMed ID: 7774281
    [No Abstract]   [Full Text] [Related]  

  • 24. Triggering of antitumor activity through melanoma-specific transduction of a constitutively active tumor necrosis factor (TNF) R1 chimeric receptor in the absence of TNF-alpha.
    Bazzoni F; Regalia E
    Cancer Res; 2001 Feb; 61(3):1050-7. PubMed ID: 11221832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovirus-induced liver pathology is mediated through TNF receptors I and II but is independent of TNF or lymphotoxin.
    Hayder H; Blanden RV; Körner H; Riminton DS; Sedgwick JD; Müllbacher A
    J Immunol; 1999 Aug; 163(3):1516-20. PubMed ID: 10415054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of TNF and lymphotoxin on the hematopoietic system.
    Trinchieri G
    Immunol Ser; 1992; 56():289-313. PubMed ID: 1550864
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease?
    Matsuyama T; Kobayashi N; Yamamoto N
    AIDS; 1991 Dec; 5(12):1405-17. PubMed ID: 1814326
    [No Abstract]   [Full Text] [Related]  

  • 28. Modulation of colony-stimulating factor-1 receptors on macrophages by tumor necrosis factor.
    Shieh JH; Peterson RH; Warren DJ; Moore MA
    J Immunol; 1989 Oct; 143(8):2534-9. PubMed ID: 2551961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tumor necrosis factor alpha and beta (TNF-alpha and -beta) in pathogenesis of rheumatoid arthritis].
    Yamamura M
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():145-52. PubMed ID: 15799335
    [No Abstract]   [Full Text] [Related]  

  • 30. Modulation of death receptor signalling.
    Schneider P; Tschopp J
    Symp Soc Exp Biol; 2000; 52():31-42. PubMed ID: 12090018
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of TNF and lymphotoxin on bone cells.
    Mundy GR; Roodman GD; Bonewald LF; Yoneda T; Sabatini M
    Immunol Ser; 1992; 56():483-98. PubMed ID: 1550873
    [No Abstract]   [Full Text] [Related]  

  • 32. Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta).
    Ruddle NH
    Curr Opin Immunol; 1992 Jun; 4(3):327-32. PubMed ID: 1329840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of TNF in regulation of cell function.
    Espevik T; Shalaby R; Liabakk NB; Waage A; Sundan A
    Scand J Clin Lab Invest Suppl; 1990; 202():160. PubMed ID: 1963703
    [No Abstract]   [Full Text] [Related]  

  • 34. Recent clinical experience with tumor necrosis factor and advances in understanding its physiologic function and cellular activities.
    Silverman P; Berger NA
    Curr Opin Oncol; 1990 Dec; 2(6):1133-8. PubMed ID: 2099843
    [No Abstract]   [Full Text] [Related]  

  • 35. The biology of cachectin/TNF--a primary mediator of the host response.
    Beutler B; Cerami A
    Annu Rev Immunol; 1989; 7():625-55. PubMed ID: 2540776
    [No Abstract]   [Full Text] [Related]  

  • 36. The biochemistry and pharmacology of TNF alpha and beta, 21 April 1995, New York.
    Carty TJ; Gilman SC
    Inflamm Res; 1995 Nov; 44(11):455-7. PubMed ID: 8597876
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.
    Spahn TW; Eugster HP; Fontana A; Domschke W; Kucharzik T
    Infect Immun; 2005 Nov; 73(11):7077-88. PubMed ID: 16239501
    [No Abstract]   [Full Text] [Related]  

  • 38. Response to the letter to the editor.
    Etemadi N; Silke J; Nachbur U
    Immunol Cell Biol; 2014 Apr; 92(4):301-2. PubMed ID: 24751613
    [No Abstract]   [Full Text] [Related]  

  • 39. Progranulin inhibition of TNFα.
    Uddin SM; Mundra JJ; Jian J; Tian Q; Gonzalez-Gugel E; Richbourgh B; Liu CJ
    Immunol Cell Biol; 2014 Apr; 92(4):299-300. PubMed ID: 24518982
    [No Abstract]   [Full Text] [Related]  

  • 40. TNF signal transduction and TNF-responsive genes.
    Krönke M; Schütze S; Scheurich P; Pfizenmaier K
    Immunol Ser; 1992; 56():189-216. PubMed ID: 1312872
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.